Christina L. Zamarro - Jan 1, 2023 Form 3 Insider Report for GOODYEAR TIRE & RUBBER CO /OH/ (GT)

Role
EVP & Chief Financial Officer
Signature
/s/ Daniel T Young, signing as an attorney-in-fact and agent duly authorized to execute this Form 3 on behalf of Christina L. Zamarro pursuant to a Power of Attorney dated December 20, 2022, a copy of which is filed herewith.
Stock symbol
GT
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/11/2023, 12:05 PM
Previous filing
Aug 3, 2022
Next filing
Feb 6, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GT Common Stock 6.31K Jan 1, 2023 Direct
holding GT Common Stock 578 Jan 1, 2023 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GT 2017 Plan Restricted Stock Units Jan 1, 2023 Common Stock 16.6K Direct F2, F3
holding GT 2017 Plan Restricted Stock Units Jan 1, 2023 Common Stock 7.32K Direct F2, F4
holding GT 2017 Plan Restricted Stock Units Jan 1, 2023 Common Stock 8.72K Direct F2, F5
holding GT 2017 Plan Performance Share Units Jan 1, 2023 Common Stock 11.1K Direct F6
holding GT 2017 Plan Performance Share Units Jan 1, 2023 Common Stock 4.88K Direct F7
holding GT 2017 Plan Performance Share Units Jan 1, 2023 Common Stock 5.81K Direct F8
holding GT 2017 Plan Option Jan 1, 2023 Common Stock 25K $10.12 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total number of shares of common stock allocated to the account of the reporting person in a Trust established under Goodyear's Employee Savings Plan for Salaried Employees, 401(k) Plan, as of January 1, 2023 as reported by the Plan Trustee.
F2 Restricted Stock Units, each equivalent to a share of common stock, granted under the 2017 Performance Plan.
F3 The Restricted Stock Units vest and convert into shares of common stock on May 5, 2023.
F4 The Restricted Stock Units vest and convert into shares of common stock on February 26, 2024.
F5 The Restricted Stock Units vest and convert into shares of common stock on February 28, 2025.
F6 Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2023. The number of Units paid, which can range from 0% to 150% of the Units reported on this Form 3, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2022, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2022.
F7 Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2024. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 3, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2023, and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. the S&P 500 over the 3-year period ending December 31, 2023.
F8 Performance Share Unit grant under the 2017 Performance Plan, contingently payable (to the extent earned) 100% in shares of common stock in February 2025. The number of Units paid, which can range from 0% to 200% of the Units reported on this Form 3, depends on the attainment of certain performance targets over a 3-year period ending December 31, 2024 and is subject to further increase or decrease of up to 20% based on the Company's total shareholder return vs. a peer group over the 3-year period ending December 31, 2024.
F9 Non-Qualified Stock Option in respect of shares of common stock granted under the 2017 Performance Plan.
F10 The option vests and becomes exercisable in 25% increments over four years commencing one year after the date of grant (February 25, 2020).